SCHEDULE: Armistice Capital Reports 4.99% Stake in Wearable Devices Ltd.

Sentiment:

Schedule 13G Filing


Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 167,513 ordinary shares, representing 4.99% of Wearable Devices Ltd.

Summary

  • Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, indicating their beneficial ownership of 167,513 ordinary shares of Wearable Devices Ltd.
  • This holding represents 4.99% of the class of securities, keeping them just below the 5% reporting threshold.
  • Armistice Capital, LLC acts as the investment manager for the Master Fund, which is the direct holder of the shares.
  • Steven Boyd, as the managing member of Armistice Capital, LLC, may be deemed to beneficially own these shares.
  • The filing is made under Rule 13d-1(b) and is an amendment (Amendment No. 2) to a previous filing.
  • The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership that keeps the reporting entity just under the 5% threshold, indicating no aggressive stake-building or significant shift in control.

Positives

  • The reporting persons maintain a significant, though not controlling, stake in the company.
  • The filing indicates a stable investment position rather than aggressive accumulation.
  • The reporting persons are acting in compliance with SEC disclosure requirements.

Negatives

  • The filing does not provide any new strategic information or financial performance data for Wearable Devices Ltd.
  • The beneficial ownership is held indirectly through a Master Fund, adding a layer of complexity.

Risks

  • The filing does not explicitly mention any new risks or changes to existing risk factors for Wearable Devices Ltd.

Future Outlook

No forward-looking statements or guidance specific to Wearable Devices Ltd. are provided in this filing. The filing pertains to ownership disclosure.

Management Comments

  • Armistice Capital, LLC exercises voting and investment power over the securities held by the Master Fund.
  • Steven Boyd, as the managing member of Armistice Capital, may be deemed to beneficially own the securities.
  • The Master Fund disclaims beneficial ownership due to its Investment Management Agreement with Armistice Capital.
  • The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment managers who acquire a significant stake in a public company. This filing indicates Armistice Capital's continued interest in Wearable Devices Ltd., maintaining a position just below the 5% threshold that would trigger more stringent reporting requirements.

Comparison to Industry Standards

  • This filing is a standard Schedule 13G disclosure, typical for investment firms managing assets on behalf of others.
  • The 4.99% ownership level is a common threshold for institutional investors to report beneficial ownership without triggering active control implications.
  • Competitors in the wearable technology space often see similar filings from various investment entities, reflecting the sector's attractiveness.

Related Party Transactions

  • Armistice Capital, LLC is the investment manager of Armistice Capital Master Fund Ltd.
  • Steven Boyd is the managing member of Armistice Capital, LLC.

Stakeholder Impact

  • Shareholders: The filing confirms a significant institutional investor's position, which can influence market perception but does not indicate an immediate change in control or strategy.
  • Management: The filing does not directly impact management's operational decisions but confirms an active institutional investor's presence.
  • Creditors: No direct impact is indicated as the filing is about equity ownership, not debt.

Next Steps

  • Continued monitoring of Armistice Capital's ownership stake in Wearable Devices Ltd.
  • Subsequent amendments to Schedule 13G will be filed if ownership levels change significantly.

Key Dates

DateDescription
2026-06-30Date of Event Which Requires Filing of this Statement
2026-08-14Date of Certification and Signature

Keywords

Schedule 13G, Beneficial Ownership, Wearable Devices Ltd., Armistice Capital, Steven Boyd, Ordinary Shares, SEC Filing, Investment Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.